MEDMETRICS INC.


  • Home Page
  • What we do
  • About us
  • Clients
  • Publications
  • Contact Us
  • Careers

WHAT WE DO



MedMetrics Inc. is a full-service healthcare research and consulting firm with global expertise across the research lifecycle—from study design to analysis, reporting, and publication. We specialize in health economics and outcomes research, and epidemiology delivering rigorous, reproducible evidence-based research grounded in strong scientific methodology. Our multidisciplinary team is committed to high-impact research and producing work suitable for publication in leading peer-reviewed journals. We support clients across the public and private sectors, including government, academia, and life sciences, and have experience across diverse therapeutic and policy areas. From protocol development to dissemination, MedMetrics Inc., provides end-to-end research solutions that inform decision-making, advance scientific knowledge, and improve health outcomes.



​



Our Core Research Areas



A brief overview of our core research areas, however, please contact us to discuss your research needs in detail to see how we might assist.



Health Economic Modeling



• Cost-effectiveness analysis (CEA), cost-utility analysis (CUA), budget impact models (BIM)

• Utility mapping and QALY estimation and patient reported outcome measures for HEOR

​• Markov, decision tree, and microsimulation models

• Model adaptation for different jurisdictions (e.g., HTA bodies)

• Sensitivity and scenario analyses


This is often the centerpiece of HEOR value for payers and HTA submissions.



Systematic Literature Reviews & Evidence Synthesis



• Systematic and targeted literature reviews following PRISMA guidelines

• Evidence gap analysis


Critical for establishing clinical and economic evidence foundations.



Real-World Evidence & Epidemiology



• Observational study design (cohort, case-control, cross-sectional)

• Database and registry analyses

• Burden of illness studies

• Treatment pattern and utilization studies


Increasingly essential for demonstrating value beyond clinical trials.



Health Technology Assessment (HTA) Support



• Dossier development (e.g., CADTH, NICE, ICER submissions)

• Value dossiers and reimbursement strategy

• Payer evidence requirements mapping


Directly tied to market access and reimbursement success.



Statistical Analysis and Advanced Analytics



• Biostatistics for clinical and observational data

• Survival analysis, regression modeling, causal inference

• Data visualization and reproducible analytics


Ensures methodological rigor and credibility.



Publication & Scientific Communication



• Manuscript development for peer-reviewed journals

• Conference abstracts, posters, and presentations

• Value communication materials (white papers, policy briefs)


High-impact publications build both client and firm credibility.



Market Access & Global Pricing Strategy




• Value proposition development to support global launch strategies

• Multiple pricing and reimbursement strategies

• Competitive landscape and payer insights


Bridges the gap between evidence and commercial success.



Policy & Population Health Research



• Health system and policy evaluation

• Equity and access studies (e.g. Indigenous and underserved populations)

• Public health impact modeling


Particularly valuable for government and global health clients.



© 2026 - MedMetrics Inc.